Preparation and first evaluation of [(18)F]FE@SUPPY: a new PET tracer for the adenosine A(3) receptor.

[1]  W. Wadsak,et al.  [18F]FETO: metabolic considerations , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  Gil Ohana,et al.  The A3 Adenosine Receptor Is Highly Expressed in Tumor versus Normal Cells , 2004, Clinical Cancer Research.

[3]  R. Blakely,et al.  Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. , 2004, Molecular pharmacology.

[4]  C. Psarropoulou,et al.  The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices , 2004, Epilepsy Research.

[5]  L. Griffiths,et al.  Age-related changes in cardiac adenosine receptor expression , 2004, Mechanisms of Ageing and Development.

[6]  R. Cunha,et al.  Adenosine A3 receptors are located in neurons of the rat hippocampus , 2003, Neuroreport.

[7]  P. Fishman,et al.  Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. , 2003, Anticancer research.

[8]  Richard A Stone,et al.  Knockout of A3 adenosine receptors reduces mouse intraocular pressure. , 2002, Investigative ophthalmology & visual science.

[9]  P. Fishman,et al.  A3 adenosine receptor as a target for cancer therapy. , 2002, Anti-cancer drugs.

[10]  K. Varani,et al.  A3 Adenosine Receptors in Human Neutrophils and Promyelocytic HL60 Cells: A Pharmacological and Biochemical Study , 2002 .

[11]  K. Varani,et al.  Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line , 2001, British journal of pharmacology.

[12]  Kyong-Tai Kim,et al.  Pharmacological characterization of adenosine receptors in PGT‐β mouse pineal gland tumour cells , 2001 .

[13]  R. Lin,et al.  Right Thing at a Wrong Time?. Adenosine A3 Receptors and Cerebroprotection in Stroke , 2001, Annals of the New York Academy of Sciences.

[14]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  G. Spalluto,et al.  A3 Adenosine Receptor Ligands: History and Perspectives , 2000, Medicinal research reviews.

[16]  R. Lin,et al.  Stimulation of Adenosine A3 Receptors in Cerebral Ischemia: Neuronal Death, Recovery, or Both? , 1999, Annals of the New York Academy of Sciences.

[17]  S. Moro,et al.  Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. , 1999, Journal of medicinal chemistry.

[18]  K. Jacobson,et al.  A physiological role of the adenosine A3 receptor: sustained cardioprotection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Okada,et al.  Effects of Adenosine Receptor Subtypes on Hippocampal Extracellular Serotonin Level and Serotonin Reuptake Activity , 1997, Journal of neurochemistry.

[20]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .